On August 11, 2016, Richard A. Kaplan, CEO of CurAegis Technologies Inc, announced that the company has entered into agreements with six companies to participate in the beta trials for the CURA fatigue management system.The organizations represent 5 of our initial 8 target markets, which include: trucking, busing, aviation, medical, general corporate, sports science, municipal agencies, and federal agencies.
The CURA System Beta Trials are set to begin in the fourth quarter of 2016.
Kaplan says in a release, “We are very excited about the enthusiasm we have seen for this breakthrough technology. We are very appreciative to these organizations for their interest in validating and improving the technology underlying the CURA System.”
The three priorities of the beta trials are: user acceptance, ease of implementation, and efficacy of the technology.
After the completion of the beta trials, the company will begin paid pilot programs.
